Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 14, 2008, Pages 1375-1376

  Nazarian, Saman ^a   Lima, João A C ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEART ARRHYTHMIA; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT;

CARDIOMYOPATHY, HYPERTROPHIC; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; TACHYCARDIA;

EID: 41149139515     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.01.010     Document Type: Editorial

References (24)

1. Maron B.J., Spirito P., Shen W.K., et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412
2. Elliott P.M., Gimeno J.R., Thaman R., et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart 92 (2006) 785-791
3. Cecchi F., Olivotto I., Montereggi A., Santoro G., Dolara A., and Maron B.J. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26 (1995) 1529-1536
4. Cecchi F., Maron B.J., and Epstein S.E. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 13 (1989) 1283-1288
5. Schron E.B., Exner D.V., Yao Q., et al. Quality of life in the Antiarrhythmics Versus Implantable Defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105 (2002) 589-594
6. Connolly S.J., Dorian P., Roberts R.S., et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. Jama 295 (2006) 165-171
7. Maron B.J., Lipson L.C., Roberts W.C., Savage D.D., and Epstein S.E. "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol 41 (1978) 1133-1140
8. Priori S.G., Aliot E., Blomstrom-Lundqvist C., et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22 (2001) 1374-1450
9. Maron B.J., Savage D.D., Wolfson J.K., and Epstein S.E. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 48 (1981) 252-257
10. Monserrat L., Elliott P.M., Gimeno J.R., Sharma S., Penas-Lado M., and McKenna W.J. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 42 (2003) 873-879
11. Adabag A.S., Casey S.A., Kuskowski M.A., Zenovich A.G., and Maron B.J. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 45 (2005) 697-704
12. Sadoul N., Prasad K., Elliott P.M., Bannerjee S., Frenneaux M.P., and McKenna W.J. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 96 (1997) 2987-2991
13. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
14. Maron B.J., Carney K.P., Lever H.M., et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 41 (2003) 974-980
15. Bello D., Fieno D.S., Kim R.J., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 (2005) 1104-1108
16. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007) 2006-2014
17. Nazarian S., Bluemke D.A., Lardo A.C., et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112 (2005) 2821-2825
18. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 (2006) 32-39
19. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1977-1985
20. Varnava A.M., Elliott P.M., Mahon N., Davies M.J., and McKenna W.J. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88 (2001) 275-279
21. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
22. Teraoka K., Hirano M., Ookubo H., et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 22 (2004) 155-161
23. Dimitrow P.P., Klimeczek P., Vliegenthart R., et al. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging 24 (2008) 77-83
24. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., and Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in Young Adults. Circulation 92 (1995) 785-789